Lv1
30 积分 2023-04-24 加入
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
1个月前
已完结
Radiolabeled HER2-targeted molecular probes in breast cancer imaging: current knowledge and future prospective
1个月前
已完结
Radiolabeled HER2-targeted molecular probes in breast cancer imaging: current knowledge and future prospective
2个月前
已完结
Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma
2个月前
已完结
Predicting prognosis of locally advanced esophageal squamous cell carcinoma through early changes in neutrophil-to-lymphocyte ratio following neoadjuvant immunochemotherapy
2个月前
已完结
Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study
2个月前
已完结
Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging
1年前
已完结
Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer
1年前
已完结
[Current status and prospect of treatment for esophageal cancer in the era of precision medicine]
2年前
已完结
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
2年前
已完结
皖公网安备34019202002308
